Connect with us

Hi, what are you looking for?

Tuesday, Aug 16, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

International

UK medical pot patients asked for feedback to improve industry

Patients First is a response to U.K. patients voicing frustrations over the quality of legal medical cannabis

Cannabis is small jar next to a stack of notebooks
Patients First wants to use feedback from medical cannabis users to guide the industry in a sustainable direction. Image via Pexels

An initiative in the United Kingdom wants to pay medical cannabis patients for feedback to improve the industry.

Advocacy organization Volteface has partnered with cannabis consultancy group Maple Tree Consultants to launch Patients First, a program that will pay patients for participating in professionally facilitated focus groups.

Volteface says the scheme, kicking off on Thursday, was created in response to a significant number of patients voicing their frustrations on social media about the quality of medical cannabis in the U.K.

Patients First has been set up to promote a patient-led practice so the industry can engage with medical cannabis patients, says Katya Kowalski, head of operations at Volteface.

“At the moment there is a significant disconnect between patients and industry groups in the U.K. medical cannabis sector. Patients often feel their perspectives are not being heard by the industry,” she says in a statement.

Read more: UK’s medical pot industry could reach £1.2B through reform: report

Read more: UK medical pot patients see positive changes and few adverse effects

The initiative seeks constructive feedback on patient experiences with medical cannabis. The information from the focus groups will aim to guide the industry in a sustainable direction, while giving patients a formal outlet to voice their concerns.

Any patient taking medical cannabis in the U.K. can sign up for the initiative through a secure database. All data will remain confidential, and patients can participate anonymously or use a pseudonym. They’ll be paid for their time.

Volteface points out that failing to listen patients’ needs risks fuelling the illicit market if they lose faith in legally supplied pot.

A Volteface report estimates about 2,500 patients in the U.K. access medical cannabis through a private prescription. But it’s too expensive, so about 1.4 million people self-medicate with illicit weed.

While access poses a challenge, medical cannabis patients have seen positive effects from treatment.

A recent analysis of medical cannabis users’ experiences in the U.K. found that it seems to be effective for a range of conditions, and is more tolerable than other commonly prescribed medications.

Read more: Clinical trial in UK to look at medical cannabis as treatment for long Covid

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Kathryn Tindale on Twitter

kathryn@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Business

According to Brightfield Group, the number of CBD consumers doubled in 2019 and reached over 7 per cent of the adult population in 2020

Business

This April, Pure Extracts Manufacturing Corp. received an IPO from the Nova Scotia Liquor Corporation Cannabis for its vapes and hemp-based edibles

Canada

The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients

Analysis

Price is the main reason consumers purchase illegal cannabis, according to a recent report in the Journal of Studies on Alcohol and Drugs